# 2026-10187: FDA Seeks Comments on Cigarette Warning Rules

2026-10187, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Required Warnings for Cigarette Packages and Advertisements, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-21, effective Submit written comments (including recommendations) on the collection of information by June 22, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-10187
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-10187
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Required Warnings for Cigarette Packages and Advertisements
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 29964
- Published: 2026-05-21
- Effective: Submit written comments (including recommendations) on the collection of information by June 22, 2026.
- Comments close: 2026-06-22
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Seeks Comments on Cigarette Warning Rules

## Summary

The FDA is asking for public comments on continuing to collect info about the required health warnings on cigarette packs and ads. This affects tobacco companies who must keep using these graphic warnings to show smoking’s dangers. Comments are due by June 22, 2026, and this review helps keep the rules clear without adding extra costs.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-10187 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/21/2026-10187/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-10187 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-21/pdf/2026-10187.pdf)

## Related
- [Previous: 2026-10185, Notice of Intent To Prepare an Environmental Impact Statement (EIS) for Basing…](https://policyrisk.com/federal-register/2026-10185)
- [Next: 2026-10188, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-10188)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-10187 (as of 2026-06-08).
